Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dorisol
- Development stage
- Unknown
- Lead developer
- PharmaSGP
- Administration
- Oral
01
Overview
Dorisol is an over-the-counter homeopathic combination drug developed and marketed by PharmaSGP. It is formulated as oral tablets containing a complex of five plant-derived homeopathic active ingredients: Gelsemium sempervirens, Spigelia anthelmia, Iris versicolor, Cyclamen purpurascens, and Cimicifuga racemosa. Dorisol is approved and marketed in Germany and other European countries for the treatment of pain, specifically targeting neuralgia (nerve pain), headaches, and migraines.
- Brand names
- Dorisol
Beyond the preview
Go deeper on Dorisol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dorisol.